What is the Charles River Laboratories Intl. Inc (CRL) price today?

The price of Charles River Laboratories Intl. Inc (CRL) today is $167.75. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/CRL

Buy & Sell Charles River Laboratories Intl. Inc (CRL) – Charles River Laboratories Intl. Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

Charles River Laboratories (CRL) trades at $166.79, down 4.08% amid mixed technical signals. The stock shows strong analyst support with 24 buy ratings and a $208.33 consensus price target, representing 25% upside potential. Recent Q4 2025 earnings beat expectations with $2.39 EPS versus $2.33 estimate, though revenue declined 2.6% organically. The company raised 2026 profit guidance following divestiture of underperforming assets to IQVIA and GI Partners.

CRL presents a compelling long-term value opportunity with solid institutional backing, though near-term headwinds include declining organic revenue and negative profit margins. The company's strategic asset sales and improved demand outlook for drug development services support the bullish analyst consensus, but execution risks and competitive pressures warrant monitoring.

Read full analysis

Key Stats

Market Cap
$8.37B
Sector
Health
3M Drawdown
-32.98%
Enterprise Value
$10.72B
Dividend Yield
-
Typical Hold Time
31 days

$167.75

52W Low: $99.75

11 Apr 2025

52W High: $226.77

21 Jan 2026

Charles River Laboratories Intl. Inc (CRL) is currently valued at a market capitalization of $8.37B, with an enterprise value of $10.72B. Over the past 52 weeks, Charles River Laboratories Intl. Inc has traded between a low of $99.75 and a high of $226.77, highlighting its annual price range. Over the past three months, Charles River Laboratories Intl. Inc has recorded a drawdown of -32.98%, reflecting recent price volatility. Charles River Laboratories Intl. Inc offers a dividend yield of -. On average, investors hold Charles River Laboratories Intl. Inc for approximately 31 days, indicating typical investor behavior on the platform.

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Technical Indicators

Overall Summary

Bearish (1)Neutral (12)Bullish (14)

News

Benzinga5 mon ago

Charles River Beat Expectations But Why Is The Stock Falling?

Globe Newswire5 mon ago

Cell-based Assays Market Size to Reach USD 35.34 Billion by 2032, Driven by Demand for Drug Discovery and Advanced Biotechnology Research – SNS Insider

Globe Newswire5 mon ago

Cell & Gene Therapy Quality Control Market Poised USD 22.81 Billion at 25.74% CAGR by 2034

Globe Newswire6 mon ago

Biologics Safety Testing Market to Rise at 13.64% CAGR, Soars USD 14.45 Bn by 2034

Globe Newswire6 mon ago

Pharmaceutical Contract Research Services Market Report 2025-2035: M&A, Partnerships, and Biologics Focus

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$8.37B
Sector
Health
3M Drawdown
-32.98%
Enterprise Value
$10.72B
Dividend Yield
-
Typical Hold Time
31 days

$167.75

52W Low: $99.75

11 Apr 2025

52W High: $226.77

21 Jan 2026

Let’s invest in this asset by signing up or download!

Buy & Sell Charles River Laboratories Intl. Inc (CRL) – Charles River Laboratories Intl. Inc Price Today

Aura AI Summary

Key Stats

About Charles River Laboratories Intl. Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store